Gene · 11284
Papers2,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Eukaryotic RNA-guided endonucleases evolved from a unique clade of bacterial enzymes. | Nucleic Acids Res | 2023 | 37971304 | PubTator, text mining | PubMed |
| Deep learning of human polyadenylation sites at nucleotide resolution reveals molecular determinants of site usage and relevance in disease. | Nat Commun | 2023 | 37968271 | PubTator, text mining | PubMed |
| Modular vector assembly enables rapid assessment of emerging CRISPR technologies. | bioRxiv | 2023 | 37961518 | PubTator, text mining | PubMed |
| Targeting the DNA Damage Response for Cancer Therapy. | Int J Mol Sci | 2023 | 37958890 | PubTator, text mining | PubMed |
| CLIP-Seq analysis enables the design of protective ribosomal RNA bait oligonucleotides against C9ORF72 ALS/FTD poly-GR pathophysiology. | Sci Adv | 2023 | 37948524 | PubTator, text mining | PubMed |
| TDP1 suppresses chromosomal translocations and cell death induced by abortive TOP1 activity during gene transcription. | Nat Commun | 2023 | 37945566 | PubTator, text mining | PubMed |
| Rational design of microRNA-responsive switch for programmable translational control in mammalian cells. | Nat Commun | 2023 | 37938567 | PubTator, text mining | PubMed |
| MePMe-seq: antibody-free simultaneous m6A and m5C mapping in mRNA by metabolic propargyl labeling and sequencing. | Nat Commun | 2023 | 37935679 | PubTator, text mining | PubMed |
| Impact of germline DNA repair gene variants on prognosis and treatment of men with advanced prostate cancer. | Sci Rep | 2023 | 37932350 | PubTator, text mining | PubMed |
| Combined in vitro/in vivo genome-wide CRISPR screens in triple negative breast cancer identify cancer stemness regulators in paclitaxel resistance. | Oncogenesis | 2023 | 37932309 | PubTator, text mining | PubMed |
| SLC3A2 N-glycosylation and Golgi remodeling regulate SLC7A amino acid exchangers and stress mitigation. | J Biol Chem | 2023 | 37918808 | PubTator, text mining | PubMed |
| Multiplexed assay of variant effect reveals residues of functional importance in the BRCA1 coiled-coil and serine cluster domains. | PLoS One | 2023 | 37917606 | PubTator, text mining | PubMed |
| Sperm DNA fragmentation testing in clinical management of reproductive medicine. | Reprod Med Biol | 2023 | 37915974 | PubTator, text mining | PubMed |
| Glioma synapses recruit mechanisms of adaptive plasticity. | Nature | 2023 | 37914930 | PubTator, text mining | PubMed |
| Overexpression of XRCC1 is Associated with Poor Survival in Patients with Head and Neck Squamous Carcinoma and Has Potential to Be Used as Targeted Therapy by Synthetic Lethality. | Asian Pac J Cancer Prev | 2023 | 37898859 | PubTator, text mining | PubMed |
| ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification. | J Biol Chem | 2023 | 37898399 | PubTator, text mining | PubMed |
| DNA damage and repair: underlying mechanisms leading to microcephaly. | Front Cell Dev Biol | 2023 | 37881689 | PubTator, text mining | PubMed |
| PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies. | Cancer Res Commun | 2023 | 37861290 | PubTator, text mining | PubMed |
| lhCLIP reveals the in vivo RNA-RNA interactions recognized by hnRNPK. | PLoS Genet | 2023 | 37851698 | PubTator, text mining | PubMed |
| The landscape of small nucleolar RNA expression in multiple myeloma is determined by cytogenetic alterations. | Leukemia | 2023 | 37845284 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11284/papers?page=8